David L Nelson

This inventor holds 4 USPTO granted patents. Top assignees: Baylor College of Medicine, Other. Active years: 2000-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David L Nelson. Retrieved from https://idiyas.com/inventor/david-l-nelson-8uty5tm7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 39(Granted Patents)

Location History:

Houston, TX (US) (2000 - 2004)
Sunset Beach, NC (US) (2020)

Company Filing History:

2 out of 619

Baylor College of Medicine

patents

2 out of 834,570

Other

patents

Years Active: 2000-2020

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10801222 - Separately owned workshops with shared central building (2020-10-13),

2. 6824972 - Diagnosis and treatment of medical conditions associated with defective NFkappa B(NF-&kgr;B) activation (2004-11-30),

3. 6180337 - Diagnosis of the fragile X syndrome (2001-01-30),

4. 6107025 - Diagnosis of the fragile X syndrome (2000-08-22),

Title: The Innovative Contributions of David L. Nelson

Introduction

David L. Nelson is a notable inventor based in Houston, TX, with a focus on innovative solutions that address both community needs and medical challenges. He holds a total of 4 patents, showcasing his diverse expertise in various fields.

Latest Patents

One of his latest patents is titled "Separately owned workshops with shared central building." This invention describes a workshop community that consists of multiple standalone workshop structures arranged around a central building. Each workshop is individually owned, while the owners collectively manage the central building and its associated infrastructure, including paths, fences, and lights. The central building serves as the administrative and social hub for the community, enhancing collaboration among workshop owners.

Another significant patent is related to the "Diagnosis and treatment of medical conditions associated with defective NFkappa B (NF-κB) activation." This invention addresses Incontinentia Pigmenti (IP), a neurocutaneous genodermatosis that is X-linked dominant and poses a high risk of prenatal male lethality. The patent discloses methods, compositions, and kits aimed at addressing defects in NF-κB related diseases, particularly focusing on the mutations found in the NF-κB Essential Modulator gene.

Career Highlights

Throughout his career, David L. Nelson has made substantial contributions to both community-oriented projects and medical research. His innovative patents reflect his commitment to improving the quality of life for individuals and communities alike.

Collaborations

David has collaborated with notable professionals such as C. Thomas Caskey and Maura Pieretti, enhancing the impact of his work through shared expertise and insights.

Conclusion

David L. Nelson's inventive spirit and dedication to addressing complex challenges through innovation are evident in his patents and collaborations. His work continues to inspire advancements in both community development and medical research.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]